Crown Bioscience Expands Partnership with NRCMM
February 12, 2015 at 10:18 AM EST
Crown Bioscience, a US-China preclinical CRO, has extended its partnership with the National Resource Center for Mutant Mice (NRCMM) to build experimental immune-oncology mouse models of along with models for diabetes and inflammation. NRCMM was established by the US National Institute of Health and has a China commercial branch, the Nanjing Biotech Innovation Corporation. Crown Bioscience is headquartered in California with labs in Beijing, Taicang, the UK and North Carolina. More details.... Share this with colleagues: // //